Ligand · 6L7
6L7 · [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-azaniumylethyl)-[(3~{S})-3-azaniumyl-4-oxidanyl-4-oxidanylidene-butyl]azanium
6L7, [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-azaniumylethyl)-[(3~{S})-3-azaniumyl-4-oxidanyl-4-oxidanylidene-butyl]azanium (C16 H29 N8 O5 +3, 413.5 g/mol), in the MolNFT structures on…
- Component
- 6L7
- Formula
- C16 H29 N8 O5 +3
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
6L7 in 1 structure; the first of them:
- 5NTC · Crystal structure of mouse CARM1 in complex with inhibitor SA0678 · 6L7 A508 · binds TYR150, PHE151, TYR154, GLN160, MET163, ARG169, GLY193, CYS194 and 14 more
Residues it binds most
GLU 4, GLY 4, MET 4, SER 4, TYR 4, VAL 4, ALA 4, ARG 4, CYS 4, GLN 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.